GranuFlo and NaturaLyte are two products that are commonly used in dialysis treatments. The products have been associated with an increased risk for cardiopulmonary arrest and sudden cardiac death. The manufacturer of GranuFlo and NaturaLyte, Fresenium Medical Care (FMC), knew about the products dangers, but they failed to the alert medical professionals and patients.
If GranuFlo or NaturaLyte were used during your dialysis treatment and you suffered an adverse side effect, you may have grounds for legal action. Contact a knowledgeable attorney today to explore your legal options.
To receive a Free Case Review, fill out the contact form on the right.
GranuFlo and NaturaLyte Side Effects
GranuFlo and NaturaLyte are dry acid products that are used in dialysis treatment to help remove waste from the blood. Unfortunately, many patients have reported serious side effects after using GranuFlo and NaturaLyte. Listed below are some adverse side effects associated with GranuFlo and NaturaLyte such as:
- Low blood pressure
- Heart attack
- Cardiac arrhythmia
- Cardiopulmonary arrest
- Sudden cardiac death
If you have experienced any of these health conditions after dialysis treatment, you may be eligible for legal and financial recourse.
To schedule a legal consultation, fill out the contact form on this page.
Fresenium Medical Care Knew About Heart Attack Risks
The Food and Drug Administration (FDA) issued a Class 1 recall of GranuFlo and NaturaLyte in March 2012. A Class 1 recall is the most serious type of recall and it involves situations where there is a reasonable probability that that use of these products will cause serious adverse health consequences or death.
FMC conducted a study that evaluated the risk factors of dialysis patients who suffered cardiopulmonary arrest in FMC facilities compared to other dialysis patients in the same facilities between January 1 and December 31, 2010.
The results from the study found that 941 patients at over 600 FMC facilities had suffered cardiopulmonary arrests resulting in death.
Researchers found that these patients had six times the risk for cardiac arrest if they had an elevated pre-dialysis bicarbonate level.
FMC was aware of the risks associated with their dialysis patients that contained sodium diacetate. The company sent out an internal memo to FMC’s doctors and dialysis facilities that warned them of the risks. However, they failed to alert the public about the risks for cardiac arrests. The public was only notified after the memo was leaked to the FDA.
Contact a Personal Injury Attorney
Every year, approximately 400,000 Americans receive dialysis treatments for kidney failure. About a third of these patients are given the dialysis products GranuFlo and NaturaLyte during treatment. Patients that are treated with these products are at an increased risk for adverse side effects and death.
If you or a loved one was given GranuFlo and NaturaLyte during dialysis treatment and suffered a heart attack, then you may have grounds for legal action. Contact an experienced personal injury lawyer today to learn about the legal rights available to GranuFlo and NaturaLyte patients. After your legal consultation, an attorney will advise you on the best course of action to take.
The attorneys at Citrin Law Firm are dedicated to helping the victims of defective products receive the justice that they deserve.
To receive a free and confidential case evaluation, complete the contact form on this page.